Some of the key players in the n-acetylcysteine market such as Zambon, Pharmzell, Manus Aktteva Biopharma, Wuxi Enovo Chemical, Xinyi Hanling Biological Engineering, Nippon Rika, Moehs, and others.
The global N-acetylcysteine market size anticipated to expand at an unwavering rate on account of the rising prevalence of chronic obstructive pulmonary disease (COPD) worldwide, highlights Fortune Business Insights™ in its report, the title” N-Acetylcysteine Market, 2021-2028”.
COPD is a type of lung disease characterized by a steady reduction in airflow and worsening breathlessness in the patient. Though manageable, it can turn life-threatening if it is not treated in time. More importantly, the incidence of COPD is increasing around the globe. According to the World Health Organization (WHO), COPD affected approximately 251 million people worldwide in 2016 and claimed roughly 3.7 million lives. Thus, the need for effective therapies and medications for COPD is heightening globally. N-Acetylcysteine, or NAC, is an essential Active Pharmaceutical Ingredient (API) for developing treatments for COPD. This substance facilitates the removal of pulmonary secretions and clears the airway, thus preventing bacteria-stimulated mucus hyper-secretion in COPD patients.
The COVID-19 pandemic has had a significant influence on the N-acetylcysteine market growth. Management of other illnesses has been put on hold as hospitals are concentrating their resources to treat COVID-19 patients. On the other hand, since COVID-19 affects the lungs, patients with severe pulmonary ailments are being given NAC, which, to some extent, aided the growth of this market amid the current crisis.
Get Sample PDF Brochure (Includes COVID-19 Impact Analysis):
Based on product type, the market has been segregated into sprays, tracheal drips, and tablets. Based on application, it is segmented into medicines, nutrition supplements, and others. Region-wise, the market has been categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The report incorporates tangible insights into the trends, drivers, and various other aspects of the market, as well as supplies actionable analysis of the factors restricting the growth of the market. Further, it contains a granular study of the different market segments and provides a detailed evaluation of the regional prospects and the competitive dynamics influencing the market.
Drivers & Restraints-
Digitization in the Chemical Industry to Spawn New Opportunities
The market for N-Acetylcysteine is being driven by digitization, which is an evolving trend in the chemical industry. Companies are capturing and analyzing critical and applicable data and deriving valuable insights using digital tools, allowing them to make better-informed and higher-quality decisions. Machine learning (ML) and artificial intelligence (AI) are examples of advanced technologies. For instance, ML is being leveraged by chemical companies to design drugs and predict toxicity in ingredients and substances. The expansion of this market is being aided by rising urbanization and globalization, especially in emerging economies. This is an exciting growth driver for this market as lung disorders such as COPD and asthma are commonly seen to be afflicting working populations residing in urban spaces. Therefore, as urban areas continue to grow, the adoption of NAC for engineering medicines is likely to increase in the forthcoming years.
Heavy Investments in Healthcare to Stimulate the North America Market
Supported by huge investments in healthcare and medical R&D, North America is projected to lead the N-acetylcysteine market share. In addition, the robust healthcare infrastructure in the US and Canada will also aid the progress of the market in the region. The regional market is also surging due to the increased research in developing medications to cure HIV.
Due to China’s broad manufacturing base, the market in Asia Pacific is expected to expand significantly. On the other hand, the use of N-acetylcysteine for preventing paracetamol poisoning is expected to drive market growth in Europe.
Presence of Small and Large Players to Bolster Market Prospects
The key raw material for acetylcysteine is L-cysteine, which is widely available. The acetylcysteine manufacturing process is also well-developed. As a result, there are several acetylcysteine manufacturers around the world. Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, and Manus Aktteva Biopharma are significant global producers of N-acetylcysteine in the world. This sector has a high level of market concentration.
July 2019: Zambon completed its transformational acquisition of Breath Therapeutics for rare respiratory diseases such as Bronchiolitis Syndrome.
Browse Complete Summary of This Research:
List of Key Players Profiled in the N-Acetylcysteine Market Report
- Manus Aktteva Biopharma
- Wuxi Enovo Chemical
- Xinyi Hanling Biological Engineering
- Nippon Rika
Read Related News:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]